Novalis LifeSciences Investments II, L.P.

Amendment
CIK: 0001890017·Pooled Investment Fund·DELAWARE·Filed: Mar 29, 2022
Total Offering

Indefinite

Amount Sold

$296,800,000

Investors

51

First Sale

Oct 29, 2021

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(c), Section 3(c), Section 3(c)(7)
Entity Type
Limited Partnership
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Marijn E. Dekkers
Related Person
PAUL MEISTER
Related Person

Company

Novalis LifeSciences Investments II, L.P.

1 LIBERTY LANE E

HAMPTON, NH, 03842

603-339-0084

SEC Filing

0001890017-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Novalis LifeSciences Investments II, L.P. Form D Filing — Indefinite | FilingFlow